默克3篮的方法是创建路线图,以逐步淘汰动物试验
Kerstin Kleinschmidt-Doerr, Frederic C Pipp1, Isabelle Colmagne-Poulard2
1Corporate Animal Affairs, Merck KGaA, Darmstadt, Germany.
ALTEX
|November 28, 2025
概括
默克公司 KGaAA
科学领域:
- 化学安全评估 化学安全评估
- 制药行业 制药行业 制药行业
- 动物测试替代品 动物测试替代品
背景情况:
- 全球路线图旨在逐步淘汰化学安全和制药领域的动物试验.
- 欧盟委员会和美国FDA等监管机构正在推动这一转型.
- 工业倡议对于开发和实施替代方法至关重要.
研究的目的:
- 介绍默克KGaA的4R计划 (取代,减少,完善,责任) 减少动物试验.
- 为分类和管理动物试验概述一个战略的三篮式方法.
- 到2032年和2040年实现大幅减少动物试验.
主要方法:
- 动物试验的分类分为三个篮子:采用,适应和评估.
- 专注于可实现的替代方案,以便立即实施.
- 为未来的替代策略进行研究的战略投资.
主要成果:
- 一种结构化的方法,到2032年减少50%的动物试验,到2040年减少75%的动物试验.
- 确定具有可用替代品的测试 (篮子1),正在开发的替代品 (篮子2) 和需要新策略的测试 (篮子3).
- 一个由EFPIA成员达成的协作协议,以采用三篮式方法.
结论:
- 三篮战略为替代动物试验提供了可行的里程碑.
- 这种方法促进了道德和可持续的科学实践.
- 像EFPIA协议一样,整个行业的协作是推进动物试验替代品的关键.
相关概念视频
Clinical Trials
11.2K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
11.2K
Drug Discovery: Overview
13.4K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
13.4K
Clinical Trials: Overview
5.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.5K
Preclinical Development: Overview
6.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
6.5K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
558
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
558
Drug Administration and Therapy Phases: Overview
2.0K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
2.0K


